A role for galectin-3 in CD13-mediated homotypic aggregation of monocytes.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 17189612)

Published in Biochem Biophys Res Commun on December 20, 2006

Authors

Paola Mina-Osorio1, Isabel Soto-Cruz, Enrique Ortega

Author Affiliations

1: Department of Immunology, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México, D.F., México. pmina@uchc.edu

Articles by these authors

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology (2009) 1.64

Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis. J Infect (2011) 1.39

Game Related Statistics Discriminating Between Starters and Nonstarters Players in Women'S National Basketball Association League (WNBA). J Sports Sci Med (2009) 1.24

Game related statistics which discriminate between winning and losing under-16 male basketball games. J Sports Sci Med (2010) 1.17

Evidence of recombination in intrapatient populations of hepatitis C virus. PLoS One (2008) 1.16

Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus. Clin Infect Dis (2012) 1.13

CD13 is a novel mediator of monocytic/endothelial cell adhesion. J Leukoc Biol (2008) 1.07

Game-related statistics that discriminated winning and losing teams from the Spanish men's professional basketball teams. Coll Antropol (2008) 1.03

Differences in game-related statistics of basketball performance by game location for men's winning and losing teams. Percept Mot Skills (2008) 1.02

A new subtype of hepatitis C virus genotype 1: complete genome and phylogenetic relationships of an Equatorial Guinea isolate. J Gen Virol (2006) 1.01

Quantity and quality of practice: interrelationships between task organization and student skill level in physical education. Res Q Exerc Sport (2011) 1.00

Clinical utility of maraviroc. Clin Drug Investig (2011) 0.96

An analysis of defensive strategies used by home and away basketball teams. Percept Mot Skills (2010) 0.95

Multiple peer group self-identification and adolescent tobacco use. Subst Use Misuse (2012) 0.95

Aminopeptidase N (CD13) functionally interacts with FcgammaRs in human monocytes. J Leukoc Biol (2005) 0.94

CD13 in cell adhesion: aminopeptidase N (CD13) mediates homotypic aggregation of monocytic cells. J Leukoc Biol (2006) 0.93

Epidemic dynamics of two coexisting hepatitis C virus subtypes. J Gen Virol (2007) 0.90

Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients. HIV Clin Trials (2012) 0.89

Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment. J Med Virol (2008) 0.89

Signal regulators in FcR-mediated activation of leukocytes? Trends Immunol (2004) 0.89

Antigen presentation by a macrophage-like cell line persistently infected with respiratory syncytial virus. Virus Res (2004) 0.88

Match Duration and Number of Rallies in Men's and Women's 2000-2010 FIVB World Tour Beach Volleyball. J Hum Kinet (2012) 0.88

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis (2012) 0.88

Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy. Clin Infect Dis (2013) 0.87

Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain. J Acquir Immune Defic Syndr (2006) 0.87

Interferon gamma induces actin polymerization, Rac1 activation and down regulates phagocytosis in human monocytic cells. Cytokine (2011) 0.86

Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients. J Acquir Immune Defic Syndr (2009) 0.86

Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors. AIDS (2002) 0.85

Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner. Mutat Res (2002) 0.85

Contribution of insertions and deletions to the variability of hepatitis C virus populations. J Gen Virol (2007) 0.85

The changing face of HIV/AIDS in treated patients. Curr HIV Res (2009) 0.85

Aminopeptidase N (CD13) is involved in phagocytic processes in human dendritic cells and macrophages. Biomed Res Int (2013) 0.84

Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer. Cell Signal (2004) 0.84

Biotin deficiency blocks thymocyte maturation, accelerates thymus involution, and decreases nose-rump length in mice. J Nutr (2004) 0.84

Using evolutionary tools to refine the new hypervariable region 3 within the envelope 2 protein of hepatitis C virus. Infect Genet Evol (2007) 0.84

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients. AIDS (2013) 0.82

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus. J Hepatol (2013) 0.82

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection. Enferm Infecc Microbiol Clin (2014) 0.81

Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin. PLoS One (2008) 0.81

Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells. J Exp Clin Cancer Res (2011) 0.81

Persistence of decidual NK cells and KIR genotypes in healthy pregnant and preeclamptic women: a case-control study in the third trimester of gestation. Reprod Biol Endocrinol (2011) 0.81

Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment. Antimicrob Agents Chemother (2009) 0.81

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients. Hepatology (2012) 0.81

IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects. Cancer Invest (2014) 0.80

[Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy]. Enferm Infecc Microbiol Clin (2010) 0.79

Combined therapy of interferon plus ribavirin promotes multiple adaptive solutions in hepatitis C virus. J Med Virol (2009) 0.79

Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study. J Acquir Immune Defic Syndr (2014) 0.79

Analysis of proteins binding to the ITAM motif of the beta-subunit of the high-affinity receptor for IgE (FcepsilonRI). J Recept Signal Transduct Res (2007) 0.77

[Evaluation of the costs of transient elastography (FibroScan(®)) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus]. Enferm Infecc Microbiol Clin (2011) 0.76

Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000. HIV Clin Trials (2002) 0.76

Effect of antiviral treatment and host susceptibility on positive selection in hepatitis C virus (HCV). Virus Res (2007) 0.76

Syk and Lyn phosphorylation induced by FcgammaRI and FgammaRII crosslinking is determined by the differentiation state of U-937 monocytic cells. Immunol Lett (2005) 0.76

Dexamethasone in adults with bacterial meningitis. N Engl J Med (2003) 0.75

Some factors in sanctions for unsportsmanlike behavior of players and coaches in youth soccer. Percept Mot Skills (2009) 0.75

Executive summary of the consensus document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children. Enferm Infecc Microbiol Clin (2015) 0.75

[Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection]. Enferm Infecc Microbiol Clin (2006) 0.75

Preventing Loss of Basic Activities of Daily Living and Instrumental Activities of Daily Living in Elderly: Identification of Individual Risk Factors in a Holistic Perspective. Holist Nurs Pract (2015) 0.75

[Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus]. Enferm Infecc Microbiol Clin (2014) 0.75